Tue Nov 2, 2021 – 8:43 pm EDT
(LifeSiteNews) — A former regional director for a private clinical research company provided evidence that her prior employer falsified data, unblinded trial participants, and neglected the timely follow-up of subjects experiencing adverse events as they conducted a Pfizer COVID-19 vaccine trial in the fall of 2020.
According to a report from the BMJ, Brook Jackson, a “trained clinical trial auditor” with more than “15 years’ experience in clinical research coordination and management,” worked for Ventavia Research Group of Texas for two weeks in September 2020. After repeatedly alerting her employer of the overwhelming problems in quality control of the trial, she emailed a complaint to the U.S. Food and Drug Administration (FDA) and was fired by her employer later the same day.
Paul D. Thacker of the BMJ wrote that his medical journal is in possession of “dozens of internal company documents, photos, audio recordings, and emails” provided by Jackson. One photo shows “vaccine packaging materials with trial participants’ identification numbers written on them left out in the open, potentially unblinding participants.”
“Blinding” is an important aspect for the integrity of randomized control trials. It safeguards against bias in those conducting the trail when collecting data on participants whose status of receiving the
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Christian Journal or its editors